EP0853486A4 - Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes - Google Patents
Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennesInfo
- Publication number
- EP0853486A4 EP0853486A4 EP96932773A EP96932773A EP0853486A4 EP 0853486 A4 EP0853486 A4 EP 0853486A4 EP 96932773 A EP96932773 A EP 96932773A EP 96932773 A EP96932773 A EP 96932773A EP 0853486 A4 EP0853486 A4 EP 0853486A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- viral
- aids
- cancer
- treatment
- therapeutic applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US428195P | 1995-09-25 | 1995-09-25 | |
US4281P | 1995-09-25 | ||
PCT/IB1996/001115 WO1997011667A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0853486A3 EP0853486A3 (fr) | 1997-06-12 |
EP0853486A2 EP0853486A2 (fr) | 1998-07-22 |
EP0853486A4 true EP0853486A4 (fr) | 2001-09-26 |
Family
ID=21710013
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96931214A Withdrawn EP0858327A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies |
EP96932773A Withdrawn EP0853486A4 (fr) | 1995-09-25 | 1996-09-25 | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96931214A Withdrawn EP0858327A2 (fr) | 1995-09-25 | 1996-09-25 | Utilisation de 2-mercaptoethanolamine (2-mea) et de composes aminothiols similaires, en combinaison avec du 3,5-diisopropyl-salicylate de cuivre (ii) et des composes similaires, pour le traitement et la prevention de differentes maladies |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0858327A2 (fr) |
JP (1) | JPH11514990A (fr) |
AU (2) | AU7143196A (fr) |
CA (2) | CA2233445A1 (fr) |
WO (2) | WO1997011666A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994409A (en) | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
US6384259B1 (en) | 1998-11-16 | 2002-05-07 | Medimmune Oncology, Inc. | Stable amorphous amifostine compositions and dosage form |
WO2001024803A2 (fr) * | 1999-10-04 | 2001-04-12 | John Carter | Compositions pharmaceutiques et leur utilisation |
US6811788B2 (en) | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
US7927612B2 (en) | 2000-01-19 | 2011-04-19 | Baofa Yu | Combinations and methods for treating neoplasms |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US7053072B2 (en) | 2001-05-11 | 2006-05-30 | Medimmune Oncology, Inc. | Methods for the administration of amifostine and related compounds |
FR2825923B1 (fr) * | 2001-06-15 | 2006-04-07 | Oreal | Inhibiteur de no-synthase et utilisations |
KR20030077743A (ko) * | 2002-03-26 | 2003-10-04 | 변현규 | In½ |
US7629333B2 (en) | 2002-03-29 | 2009-12-08 | Medimmune, Llc | Stable amorphous amifostine compositions and methods for the preparation and use of same |
WO2004024129A1 (fr) * | 2002-09-10 | 2004-03-25 | Samir Chachoua | Therapie induisant une remission |
GB2398497A (en) * | 2003-02-19 | 2004-08-25 | Walcom Animal Science | Composition for improving immunity of animals |
US9125874B2 (en) | 2007-11-30 | 2015-09-08 | The Ramaekers Family Trust | Administration of transfer factor for improving reproductive health |
CN101138634A (zh) | 2006-09-07 | 2008-03-12 | 于保法 | 用于治疗肿瘤的组合物 |
WO2009070788A1 (fr) | 2007-11-30 | 2009-06-04 | The Ramaekers Family Trust | Compositions et procédés d'amélioration de la fertilité |
WO2010093606A1 (fr) * | 2009-02-11 | 2010-08-19 | Martin Heath Bluth | Echange réciproque sérum/plasma pour le traitement du cancer |
AU2015353539A1 (en) | 2014-11-26 | 2017-07-13 | Baofa Yu | Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057314A (en) * | 1988-09-30 | 1991-10-15 | Whitfill Craig E | Low molecular weight antiviral factors |
DE4236069A1 (de) * | 1992-10-26 | 1994-04-28 | Werner Dr Bergmann | Arzneimittel, insbesondere für orale Einnahme |
WO1994028934A1 (fr) * | 1993-06-07 | 1994-12-22 | Center For Special Immunology | Traitement adoptif de reconstitution immunitaire pour des patients atteints d'immunodeficiences acquises |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228127A (en) * | 1978-10-06 | 1980-10-14 | International Radioimmune Systems, Inc. | Kit for detecting human chorionic gonadotropin |
US4952607A (en) * | 1982-05-27 | 1990-08-28 | International Copper Research Association, Inc. | Copper complex for treating cancer |
US5310653A (en) * | 1989-10-24 | 1994-05-10 | Board Of Regents, The University Of Texas System | Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis |
US5488042A (en) * | 1992-03-13 | 1996-01-30 | Arch Development Corporation | Method for protection against genotoxic mutagenesis |
-
1996
- 1996-09-25 EP EP96931214A patent/EP0858327A2/fr not_active Withdrawn
- 1996-09-25 CA CA002233445A patent/CA2233445A1/fr not_active Abandoned
- 1996-09-25 JP JP9513260A patent/JPH11514990A/ja not_active Ceased
- 1996-09-25 AU AU71431/96A patent/AU7143196A/en not_active Abandoned
- 1996-09-25 WO PCT/IB1996/001059 patent/WO1997011666A2/fr not_active Application Discontinuation
- 1996-09-25 WO PCT/IB1996/001115 patent/WO1997011667A2/fr not_active Application Discontinuation
- 1996-09-25 AU AU69990/96A patent/AU6999096A/en not_active Abandoned
- 1996-09-25 EP EP96932773A patent/EP0853486A4/fr not_active Withdrawn
- 1996-09-25 CA CA002233015A patent/CA2233015A1/fr not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057314A (en) * | 1988-09-30 | 1991-10-15 | Whitfill Craig E | Low molecular weight antiviral factors |
DE4236069A1 (de) * | 1992-10-26 | 1994-04-28 | Werner Dr Bergmann | Arzneimittel, insbesondere für orale Einnahme |
WO1994028934A1 (fr) * | 1993-06-07 | 1994-12-22 | Center For Special Immunology | Traitement adoptif de reconstitution immunitaire pour des patients atteints d'immunodeficiences acquises |
Non-Patent Citations (5)
Title |
---|
DATABASE WPI Section Ch Week 198113, Derwent World Patents Index; Class B04, AN 1981-005287, XP002173662 * |
LAVERY J P ET AL: "TREATMENT OF CLL AND ARC PATIENTS WITH TRANSFER FACTOR AND ISOLATION AND CHARACTERIZATION OF LOW MOLECULAR WEIGHT IMMUNOMODULATORS FROM TRANSFER FACTOR", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,MOSBY - YEARLY BOOK, INC,US, vol. 81, no. 1, 1988, pages 215, XP001010534, ISSN: 0091-6749 * |
See also references of WO9711667A3 * |
SIMONE DE C ET AL: "CLINICAL AND IMMUNOLOGIC EFFECTS OF COMBINATION THERAPY WITH INTRAVENOUS IMMUNOGLOBULINS AND AZT IN HIV-INFECTED PATIENTS", IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY,MARCEL DEKKER, NEW YORK, NY,US, vol. 13, no. 3, 1991, pages 447 - 458, XP001010493, ISSN: 0892-3973 * |
WOLF B L ET AL: "TREATMENT OF AIDS PATIENTS WITH TRANSFER FACTOR", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 79, no. 1, 1987, pages 244, XP001010503, ISSN: 0091-6749 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997011667A3 (fr) | 1997-06-12 |
WO1997011667A2 (fr) | 1997-04-03 |
AU7143196A (en) | 1997-04-17 |
JPH11514990A (ja) | 1999-12-21 |
WO1997011666A2 (fr) | 1997-04-03 |
EP0853486A2 (fr) | 1998-07-22 |
CA2233015A1 (fr) | 1997-04-03 |
EP0858327A2 (fr) | 1998-08-19 |
WO1997011666A3 (fr) | 1997-06-19 |
AU6999096A (en) | 1997-04-17 |
CA2233445A1 (fr) | 1997-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0853486A4 (fr) | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes | |
EP0853486A3 (fr) | Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes | |
EP0831873A4 (fr) | Therapie combinatoire pour le traitement d'infections virales vih et autres | |
AU3066992A (en) | Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids | |
EP2270046A3 (fr) | Procédés et compositions pour le traitement des maladies associées à hémolyse | |
IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
HUP9801216A3 (en) | Dna molecules, preparation thereof and use thereof in gene therapy | |
IL162093A0 (en) | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof | |
EP0668052A3 (fr) | Appareil de diagnostic et de traitement ultrasonore. | |
AU1227302A (en) | System and method for optimizing drug therapy for the treatment of diseases | |
AU2990695A (en) | Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer | |
ZA956993B (en) | Methods of inhibiting demyelinating and desmyelinating diseases. | |
HUP0000318A3 (en) | Tumor vaccine and process for the preparation thereof | |
HU9202095D0 (en) | Therapy and vaccine against aids | |
ZA200203269B (en) | Nucleic acids of the human ABC1 gene and their therapeutic and diagnostic application. | |
EP0795332A3 (fr) | Utilisation médicale de gamma interféron dans les maladies pulmonaires interstitielles | |
DE10083095D2 (de) | Gentransfervektoren zur Therapie von Autoimmunerkrankungen und Erkrankungen mit Immunpathogenese | |
GB9509461D0 (en) | DNA molecules and constructs and their use in the treatment of mastitis | |
AU5388299A (en) | Antibodies for use in targeted and temporary treatment of humans and animals | |
IL112993A0 (en) | Recombinant niruses, their preparation and their use in gene therapy | |
GEP20012489B (en) | Use of Natural Human α-Interferon | |
ZA93211B (en) | Enzyme castration of animals and tumor treatment. | |
IL112992A0 (en) | Recombinant viruses, their preparation and their use in gene therapy | |
EP0655919A4 (fr) | Traitement d'infections virales chez l'homme. | |
AU8760298A (en) | Coup-tfi directed therapies in the treatment of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980424 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010813 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
18D | Application deemed to be withdrawn |
Effective date: 20010403 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1015268 Country of ref document: HK |